Skip to content
10-K

Annual Report

Corvus Pharmaceuticals, Inc. CRVS

0001104659-26-027047

← back to feed
Filed
Mar 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 12, 2026 83.99M sh
Shares Diluted FY 2025 · Dec 31, 2025 79.74M sh
Shares Diluted FY 2025 · Dec 31, 2024 60.99M sh
Shares Diluted FY 2025 · Dec 31, 2023 48.03M sh
Capex FY 2025 · Dec 31, 2025 $174K
Capex FY 2025 · Dec 31, 2023 $34K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$32.8M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$25.42M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$23.94M
Cash And Equivalents FY 2025 · Dec 31, 2025 $4.58M
Cash And Equivalents FY 2025 · Dec 31, 2024 $8.74M
Stockholders Equity FY 2025 · Dec 31, 2025 $61.21M
Stockholders Equity FY 2025 · Dec 31, 2024 $32.57M
Stockholders Equity FY 2025 · Dec 31, 2023 $38.68M
Stockholders Equity FY 2025 · Dec 31, 2022 $56.12M
Current Liabilities FY 2025 · Dec 31, 2025 $9.38M
Current Liabilities FY 2025 · Dec 31, 2024 $35.4M
Total Liabilities FY 2025 · Dec 31, 2025 $9.91M
Total Liabilities FY 2025 · Dec 31, 2024 $36.34M
Current Assets FY 2025 · Dec 31, 2025 $58.21M
Current Assets FY 2025 · Dec 31, 2024 $54.41M
Total Assets FY 2025 · Dec 31, 2025 $71.12M
Total Assets FY 2025 · Dec 31, 2024 $68.91M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.53
Eps Diluted FY 2025 · Dec 31, 2024 −$1.02
Eps Diluted FY 2025 · Dec 31, 2023 −$0.56
Eps Basic FY 2025 · Dec 31, 2025 −$0.19
Eps Basic FY 2025 · Dec 31, 2024 −$1.02
Eps Basic FY 2025 · Dec 31, 2023 −$0.56
Sga Expense FY 2025 · Dec 31, 2025 $9.25M
Sga Expense FY 2025 · Dec 31, 2024 $8.16M
Sga Expense FY 2025 · Dec 31, 2023 $6.88M
Rd Expense FY 2025 · Dec 31, 2025 $33.72M
Rd Expense FY 2025 · Dec 31, 2024 $19.39M
Rd Expense FY 2025 · Dec 31, 2023 $16.53M
Net Income FY 2025 · Dec 31, 2025 −$15.28M
Net Income FY 2025 · Dec 31, 2024 −$62.29M
Net Income FY 2025 · Dec 31, 2023 −$27.03M
Operating Income FY 2025 · Dec 31, 2025 −$42.97M
Operating Income FY 2025 · Dec 31, 2024 −$27.55M
Operating Income FY 2025 · Dec 31, 2023 −$23.41M